Company Data

Freeline Therapeutics Holdings plc

Ticker
FRLN
Current Price
$6.48
Market Cap
$28.1M
Price Target
Refer to Report
Volume
358.0K
52wk Range
$ - $
Advanced Market Data

Overview

Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease and FLT201 for the treatment of Gaucher disease Type 1.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy